相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Siglecs as Immune Cell Checkpoints in Disease
Shiteng Duan et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
CD24Fc protects against viral pneumonia in simian immunodeficiency virus-infected Chinese rhesus monkeys
Ren-Rong Tian et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Targeted glycan degradation potentiates the anticancer immune response in vivo
Melissa A. Gray et al.
NATURE CHEMICAL BIOLOGY (2020)
Cross-reactivity of mouse IgG subclasses to human Fc gamma receptors: Antibody deglycosylation only eliminates IgG2b binding
A. Robin Temming et al.
MOLECULAR IMMUNOLOGY (2020)
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Alex D. Waldman et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
Jun Wang et al.
NATURE MEDICINE (2019)
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
Stacy A. Malaker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The ceramide moiety of disialoganglioside (GD3) is essential for GD3 recognition by the sialic acid-binding lectin SIGLEC7 on the cell surface
Noboru Hashimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
An Atlas of Human Glycosylation Pathways Enables Display of the Human Glycome by Gene Engineered Cells
Yoshiki Narimatsu et al.
MOLECULAR CELL (2019)
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Amira A. Barkal et al.
NATURE (2019)
Gangliosides: Treatment Avenues in Neurodegenerative Disease
Pierre J. Magistretti et al.
FRONTIERS IN NEUROLOGY (2019)
Direct fluorescent glycan labeling with recombinant sialyltransferases
Zhengliang L. Wu et al.
GLYCOBIOLOGY (2019)
Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins
Kim F. Bornhoefft et al.
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2018)
PU.1 is required for the Developmental Progression of Multipotent Progenitors to common lymphoid Progenitors
Swee Heng Milon Pang et al.
FRONTIERS IN IMMUNOLOGY (2018)
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, efficacy, and Limitations
Judith A. Seidel et al.
FRONTIERS IN ONCOLOGY (2018)
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells
Michal A. Stanczak et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors
[Anonymous]
NATURE REVIEWS DRUG DISCOVERY (2018)
C-type lectins in immunity and homeostasis
Gordon D. Brown et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Probing sialoglycans on fetal bovine fetuin with azido-sugars using glycosyltransferases
Zhengliang L. Wu et al.
GLYCOBIOLOGY (2016)
CD43 Functions as an E-Selectin Ligand for Th17 Cells In Vitro and Is Required for Rolling on the Vascular Endothelium and Th17 Cell Recruitment during Inflammation In Vivo
Francisco Velazquez et al.
JOURNAL OF IMMUNOLOGY (2016)
The lectin Siglec-G inhibits dendritic cell cross-presentation by impairing MHC class I-peptide complex formation
Yuanyuan Ding et al.
NATURE IMMUNOLOGY (2016)
The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9
Richard Beatson et al.
NATURE IMMUNOLOGY (2016)
Precision glycocalyx editing as a strategy for cancer immunotherapy
Han Xiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation
Max A. Horlbeck et al.
ELIFE (2016)
Targeted Delivery of a Sialic Acid-Blocking Glycomimetic to Cancer Cells Inhibits Metastatic Spread
Christian Bull et al.
ACS NANO (2015)
Galectin-Binding O-Glycosylations as Regulators of Malignancy
Charles J. Dimitroff
CANCER RESEARCH (2015)
CD43 expression in diffuse large B-cell lymphoma, not otherwise specified: CD43 is a marker of adverse prognosis
Xiao-Bo Ma et al.
HUMAN PATHOLOGY (2015)
An Oncogenic Protein Golgi Phosphoprotein 3 Up-regulates Cell Migration via Sialylation
Tomoya Isaji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance
Camilla Jandus et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Cancer-Associated CD43 Glycoforms as Target of Immunotherapy
Franca Maria Tuccillo et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
Jason E. Hudak et al.
NATURE CHEMICAL BIOLOGY (2014)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
Siglec-mediated regulation of immune cell function in disease
Matthew S. Macauley et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients
Branka Petricevic et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Expression of ST3GAL4 Leads to SLex Expression and Induces c-Met Activation and an Invasive Phenotype in Gastric Carcinoma Cells
Catarina Gomes et al.
PLOS ONE (2013)
Siglec-7 tetramers characterize B-cell subpopulations and leukemic blasts
Friederike Gieseke et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Density Variant Glycan Microarray for Evaluating Cross-Linking of Mucin-like Glycoconjugates by Lectins
Kamil Godula et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Cosmc is an essential chaperone for correct protein O-glycosylation
Yingchun Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
Ravindra Majeti et al.
CELL (2009)
Determination of glycosylation sites and site-specific heterogeneity in glycoproteins
Hyun Joo An et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2009)
Role of the conserved oligomeric Golgi (COG) complex in protein glycosylation
Richard D. Smith et al.
CARBOHYDRATE RESEARCH (2008)
Signaling through CD43 regulates CD4 T-cell trafficking
Purvi D. Mody et al.
BLOOD (2007)
Siglecs and their roles in the immune system
Paul R. Crocker et al.
NATURE REVIEWS IMMUNOLOGY (2007)
CD43 is a ligand for E-selectin on CLA+ human T cells
RC Fuhlbrigge et al.
BLOOD (2006)
Potent glycan inhibitors of myelin-associated glycoprotein enhance axon outgrowth in vitro
AA Vyas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Glycan array screening reveals a candidate ligand for Siglec-8
BS Bochner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen
NT Marcos et al.
CANCER RESEARCH (2004)
Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms
G Nicoll et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Sialic acid capping of CD8β core 1-O-glycans controls thymocyte major histocompatibility complex class I interaction
AM Moody et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
High resolution crystal structures of Siglec-7 - Insights into ligand specificity in the Siglec family
MS Alphey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Differential biosynthesis of polysialic or disialic acid structure by ST8Sia II and ST8Sia IV
S Kitazume-Kawaguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cutting edge: CD43 functions as a T cell counterreceptor for the macrophage adhesion receptor sialoadhesin (Siglec-1)
TK van den Berg et al.
JOURNAL OF IMMUNOLOGY (2001)
The ST3Gal-I sialyltransferase controls CD8(+) T lymphocyte homeostasis by modulating O-glycan biosynthesis
JJ Priatel et al.
IMMUNITY (2000)
分享论文
